ANTIPHONICS IVS: Financial statements 2019
CVR: 35651543
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ANTIPHONICS IVS (CVR 35651543) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 11,206 and a net result of DKK -6,694 compared with DKK 36,009 the year before. That is a decrease of 84% compared with the year before. The profit margin was -59.7%. Equity in the 2019 report amounted to DKK 4,163. The solvency ratio was 78.8%.
- Revenue
- DKK 11,206
- Gross Profit
- DKK -5,770
- Profit/Loss
- DKK -6,694
- Equity
- DKK 4,163
- Total Assets
- DKK 5,284
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 11 t. | -6 t. | -7 t. | 4 t. | - |
| 2018 | 70 t. | 45 t. | 36 t. | 13 t. | - |
| 2017 | 41 t. | 14 t. | 9 t. | 24 t. | - |
| 2016 | 45 t. | 21 t. | 16 t. | 40 t. | - |
| 2015 | 75 t. | 22 t. | -6 t. | 63 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ANTIPHONICS IVS has published its annual report for 2018. Revenue came to DKK 69,850, and the net result was DKK 36,009.
About ANTIPHONICS IVS
ANTIPHONICS IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2014. The company has been dissolved on 2 December 2021. The company was registered under the industry Indspilning af lydoptagelser og udgivelse af musik. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. Equity in the 2020 report amounted to DKK 122,533.